These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27154328)

  • 1. Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants.
    Di Gregorio S; Fernandez S; Perazzi B; Bello N; Famiglietti A; Mollerach M
    Infect Genet Evol; 2016 Sep; 43():197-202. PubMed ID: 27154328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain.
    Di Gregorio S; Fernandez S; Cuirolo A; Verlaine O; Amoroso A; Mengin-Lecreulx D; Famiglietti A; Joris B; Mollerach M
    Microb Drug Resist; 2017 Jan; 23(1):44-50. PubMed ID: 27991847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of IS
    Kleinert F; Kallies R; Hort M; Zweynert A; Szekat C; Nagel M; Bierbaum G
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584147
    [No Abstract]   [Full Text] [Related]  

  • 4. VraR Binding to the Promoter Region of
    Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy.
    Basco MDS; Kothari A; McKinzie PB; Revollo JR; Agnihothram S; Azevedo MP; Saccente M; Hart ME
    J Med Microbiol; 2019 Jun; 68(6):848-859. PubMed ID: 31136294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.
    McEvoy CR; Tsuji B; Gao W; Seemann T; Porter JL; Doig K; Ngo D; Howden BP; Stinear TP
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3240-9. PubMed ID: 23629723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
    Matsuo M; Cui L; Kim J; Hiramatsu K
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5843-53. PubMed ID: 24018261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
    Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
    J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Nagel M; Reuter T; Jansen A; Szekat C; Bierbaum G
    Int J Med Microbiol; 2011 Mar; 301(3):229-36. PubMed ID: 21115395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hVISA/VISA: diagnostic and therapeutic problems.
    Szabó J
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):1-3. PubMed ID: 19622051
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation.
    Khatib R; Riederer K; Sharma M; Shemes S; Iyer SP; Szpunar S
    J Clin Microbiol; 2015 Nov; 53(11):3543-6. PubMed ID: 26311860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Trend of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in a Tertiary Care Center of Northern India.
    Singh A; Prasad KN; Misra R; Rahman M; Singh SK; Rai RP; Tripathi A; Srivastava JK
    Microb Drug Resist; 2015 Oct; 21(5):545-50. PubMed ID: 26430942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-Resistant Staphylococcus aureus Grown on Vancomycin-Supplemented Screening Agar Displays Enhanced Biofilm Formation.
    Chang W; Ding D; Zhang S; Dai Y; Pan Q; Lu H; Luo Q; Shen J; Ma X
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7906-10. PubMed ID: 26459889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Glucose Concentration Promotes Vancomycin-Enhanced Biofilm Formation of Vancomycin-Non-Susceptible Staphylococcus aureus in Diabetic Mice.
    Hsu CY; Shu JC; Lin MH; Chong KY; Chen CC; Wen SM; Hsieh YT; Liao WT
    PLoS One; 2015; 10(8):e0134852. PubMed ID: 26244880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
    Sakoulas G; Eliopoulos GM; Moellering RC; Wennersten C; Venkataraman L; Novick RP; Gold HS
    Antimicrob Agents Chemother; 2002 May; 46(5):1492-502. PubMed ID: 11959587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
    Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
    Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains.
    Chen H; Liu Y; Zhao C; Xiao D; Zhang J; Zhang F; Chen M; Wang H
    PLoS One; 2013; 8(6):e66880. PubMed ID: 23840544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.